Economic Benefits of Subcutaneous Trastuzumab Administration: A Single Institutional Study From Karolinska University Hospital in Sweden

PLoS ONE - United States
doi 10.1371/journal.pone.0211783
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Subcutaneous Administration of Rituximab (MabThera) and Trastuzumab (Herceptin) Using Hyaluronidase

British Journal of Cancer
Cancer ResearchOncology
2013English

The Clinical Value of Autopsies at a University Hospital in Sweden

Nordic Journal of Nursing Research
2016English

Economic Administration and Institutional Management in a Decentralized Regime Mode: New Insights From Environmental Resources

International Journal of Economics and Business Administration
ManagementFinanceBusinessEconomicsAccountingEconometrics
2019English

Economic Impact of Primary Headaches in Turkey: A University Hospital Based Study: Part II

Journal of Headache and Pain
MedicineNeurologyAnesthesiologyPain Medicine
2006English

Development of a Subcutaneous Fixed-Dose Combination of Pertuzumab and Trastuzumab: Results From the Phase Ib Dose-Finding Study

Journal of Clinical Pharmacology
Pharmacology
2018English

Textbooks as eBooks -- A Case Study From the University Library of Stockholm, Sweden

Against the Grain
2013English

Institutional Factors Affecting the Academic Performance of Public Administration Students in a Nigerian University

Public Administration Research
2014English

Pcn361 - Health Economic Value Propositions for Subcutaneous Trastuzumab and Their Transferability to Central-Eastern European Countries

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Early Immune Modulation by Single-Agent Trastuzumab as a Marker of Trastuzumab Benefit

British Journal of Cancer
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy